| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2025 | 21 May 2025 |
| To consider and approve the audited financial results (Standalone & Consolidated) for the fourth quarter and financial year March 31, 2025 and other business matters BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended March 31, 2025. (As Per NSE Announcemnet Dated on: 30.05.2025) | ||
| Board Meeting | 10 Feb 2025 | 1 Feb 2025 |
| To consider and approve the financial results for the period ended December 31, 2024 and other business matters BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding outcome of Board meeting held on February 10, 2025. (As Per NSE Announcement Dated on: 10.02.2025) BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Submission of the unaudited financial results for the quarter and nine months ended 31.12.2024 in Machine Readable form/Legible Copy. (As Per NSE Announcement Dated on: 05.03.2025) | ||
| Board Meeting | 5 Nov 2024 | 29 Oct 2024 |
| BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Other business. BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Outcome of the Board meeting held on November 05, 2024. (As Per NSE Announcement Dated on: 05/11/2024) | ||
| Board Meeting | 2 Aug 2024 | 25 Jul 2024 |
| To consider and approve the financial results for the period ended Jun 30, 2024. BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Board meeting held on August 02, 2024. BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended June 30, 2024. (As Per NSE Announcement Dated on: 02/08/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.